A Closer Look at OneRF®
in Action
Press play to explore OneRF®
The first and only FDA-cleared system capable of nervous tissue ablation using the same sEEG electrode for both diagnostic and therapeutic applications.
It provides bedside monitoring, mapping and ablation, giving physicians a less invasive, potentially safer way to gain improved bedside clarity of the therapeutic window for an epilepsy patient with the possibility of seizure reduction or freedom.
INDICATIONS FOR USE
The NeuroOne OneRF® Radiofrequency Ablation System is indicated for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures. (FDA Clearance: K231675)
CAUTION: U.S. Federal law restricts this device to sale by, or on the order of, a physician.
Evo® sEEG-RF
NeuroOne Radiofrequency Generator
OneRF® Ablation System
Provides New
Therapeutic
Capability
OneRF® Is a Critical Step In The Epilepsy Care Pathway
It may allow for better understanding of the therapeutic window, keeping physicians on the path to prognostic clarity and treatment possibility. (1)
Novel
Gives patients uninterrupted, less-invasive care
Keep patients on the path to seizure freedom with a minimally-invasive step, bedside, without care interruption.
May Reduce Seizures
Potential for Seizure Freedom
May Avoid Additional Potential Invasive Surgeries
Beneficial
Designed for intuitive use and reproducible results.
OneRF® is the only FDA-cleared system designed and tested specifically for ablation using Evo® sEEG-RF.(1)
Simple Connections
Graphical Display
Modern Interface
Predictable Lesions
Intuitive
Patient Story:
Highlight of Clara’s successful treatment
After many years of Drug Resistant Epilepsy she was seizure free for months after OneRF® ablation treatment. Hear about her Epilepsy journey and OneRF® treatment.
Clara discusses her Epilepsy journey
Dr. Brin Fruend from Mayo explains Clara’s treatment
Footnotes
ALL REFERENCES ARE IN COMPANY DATA ON FILE.
IF YOU ARE INTERESTED IN LEARNING MORE PLEASE GET IN TOUCH.
SEE INSTRUCTIONS FOR USE FOR ADDITIONAL INFORMATION (EG. DESCRIPTION, INDICATIONS FOR USE, CONTRAINDICATIONS, WARNINGS, ADVERSE EVENTS ETC.)
